Shareholding disclosure
Santhera Pharmaceuticals Holding AG
Declared position
29.36%
Threshold
Crossed downwards
Timeline
Published
21.02.2018
Transaction
14.02.2018
Voting rights breakdown
Voting rights acquired0.5%
Voting rights sold29.36%
Below threshold0%
Notice details
CategorySingle shareholder
ExchangeXSWX
Notification ID
TAI2K00017
Beneficial owner
Santhera Pharmaceuticals Holding AG
Declared address
Santhera Pharmaceuticals Holding AG, 4410 Liestal
insider24.ch
Never miss a market signal again
Create a free account
Need more? Discover the Pro plan
Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open